Aprea TherapeuticsAPRE
13F holders, Q3 2024 (September 30)21holders −6
0new positions
6sold out
$2.75avg. 13F price*
At the end of Q3 2024, 21 institutions reported holding Aprea Therapeutics Inc. (APRE) in their 13F filings, down 6 from Q2 2024. 0 opened new positions and 6 sold out. The largest holders were AIGH Capital Management LLC ($1.5M), Sio Capital Management, LLC ($761K) and Sphera Funds Management LTD. ($743K).
- Company
- Aprea Therapeutics Inc.
- CUSIP
- 03836J201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 6 | $628K |
All 13F filers, Q2 2024 → Q3 2024: 72,831 shares bought and 155,687 shares sold, net −82,856 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| AIGH Capital Management LLC | 0.69% | No change | 539,300 | $1.5M |
| Sio Capital Management, LLC | 0.34% | No change | 276,603 | $761K |
| Sphera Funds Management LTD. | 0.12% | No change | 270,000 | $743K |
| Nantahala Capital Management, LLC | 0.05% | No change | 205,760 | $566K |
| Vanguard Group Inc. | 0.00% | Add +50.1% | 173,842 | $478K |
| Exome Asset Management LLC | 0.26% | No change | 137,174 | $377K |
| Stonepine Capital Management, LLC | 0.24% | No change | 137,174 | $377K |
| DAFNA Capital Management LLC | 0.09% | No change | 137,174 | $377K |
| Geode Capital Management, LLC | 0.00% | Add +12.3% | 40,067 | $110K |
| Morgan Stanley | 0.00% | Add +14.7% | 34,208 | $94K |
| Dimensional Fund Advisors LP | 0.00% | Add +54.1% | 17,064 | $47K |
| HighTower Advisors, LLC | 0.00% | No change | 13,864 | $38K |
| BlackRock, Inc. | 0.00% | — | 8,504 | $23K |
| Bank of America Corp. | 0.00% | Reduce -0.0% | 4,852 | $13K |
| Group One Trading LLC | 0.00% | No change | 2,160 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -51.8% | 1,315 | $4K |
| Mb, Levis & Associates, LLC | 0.00% | No change | 806 | $2K |
| WealthCollab, LLC | 0.00% | No change | 158 | $435 |
| Osaic Holdings, Inc. | 0.00% | Add +50.0% | 150 | $413 |
| JPMorgan Chase & Co. | 0.00% | Reduce -8.3% | 11 | $30 |
| UBS Group AG | 0.00% | No change | 3 | $8 |
"% of holder's portfolio" is APRE's weight in each manager's 13F, not the share of Aprea Therapeutics Inc. the manager owns.